Effectiveness of the Iron Chelator CN128 in Mitigating the Formation of Dopamine Oxidation Products Associated with the Progression of Parkinson’s Disease
| Autor: | Haolin Zheng, T. David Waite, Yingying Sun, Robert C. Hider, A. Ninh Pham |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Parkinson's disease
Physiology Dopamine Cognitive Neuroscience Substantia nigra Pharmacology Iron Chelating Agents Biochemistry 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine medicine Humans 030304 developmental biology chemistry.chemical_classification 0303 health sciences Reactive oxygen species Autoxidation Pars compacta Parkinson Disease Hydrogen Peroxide Cell Biology General Medicine medicine.disease chemistry Toxicity Deferiprone Oxidation-Reduction 030217 neurology & neurosurgery medicine.drug |
| Zdroj: | ACS Chemical Neuroscience. 11:3646-3657 |
| ISSN: | 1948-7193 |
| DOI: | 10.1021/acschemneuro.0c00557 |
| Popis: | The occurrence and progression of Parkinson's disease (PD) has been associated with the observation of elevated iron concentrations in the substantia nigra pars compacta (SNpc). While the reasons for the impact of elevated iron concentrations remain unclear, one hypothesis is that the presence of labile iron induces the oxidation of dopamine (DA) to toxic quinones such as aminochrome (DAC) and reactive oxygen species (ROS). As such, one of the proposed therapeutic strategies has been the use of iron chelators such as deferiprone (DFP) (which is recognized to have limitations related to its rapid degradation in the liver) to reduce the concentration of labile iron. In this study, a detailed investigation regarding the novel iron chelator, CN128, was conducted and a kinetic model developed to elucidate the fundamental behavior of this chelator. The results in this work reveal that CN128 is effective in alleviating the toxicity induced by iron and DA to neurons when DA is present at moderate concentrations. When all the iron is chelated by CN128, the formation of DAC and the oxidation of DA can be reduced to levels identical to that in the absence of iron. The production of H2O2 is lower than that generated via the autoxidation of the same amount of DA. However, when severe leakage of DA occurs, the application of CN128 is insufficient to alleviate the associated toxicity. This is attibuted to the less important role of iron in the production of toxic intermediates at high concentrations of DA. CN128 is superior to DFP with regard to the reduction in formation of DAC and elevation in DA concentration. In summary, the results of this study suggest that prodromal application of the chelator CN128 could be effective in preventing the onset and slowing the early stage development of PD symptoms associated with oxidants and toxic intermediates resulting from the iron-mediated oxidation of the neurotransmitter dopamine with CN128 likely to be superior to DFP in view of its greater in vivo availability and less problematic side effects. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|